THX-110
AssetSmall moleculeAlso THX-110 (dronabinol plus PEA)
Combination of dronabinol and palmitoylethanolamide targeting cannabinoid and PPAR-alpha pathways.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- PPARA
- Indications
- 1
- Trials
- 10
- Developers
- 1
Indications
1Tourette syndrome
Phase 2UNKNOWNNCT03651726clinicaltrials.gov7 Oct 2026
- Targets and what it contains4
- Owner and partners1
- Trials10
- Evidence for its targets3
- Competitors6
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 2 sources